cidrap.umn.edu
94%
143
News Scan for Aug 22, 2022
Nonhospitalized, high-risk, vaccinated COVID-19 patients who received nirmatrelvir-ritonavir (NMV-r, or Paxlovid) saw a 45% drop in their relative risk of emergency department (ED) visits, hospitalization, and death by 30 days, suggests a study published late last week in Clinical Infectious Diseases.A team led by Beth Israel Lahey Health researchers in Massachusetts ret